“We believe the rapid rate of enrollment of this phase 2a study is supported by our discussions with key opinion leaders who have noted that alternative new classes of IOP-lowering drugs are ...

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced it has reached the 50% patient enrollment threshold of its ... for the lowering of intraocular ...